M.D., Ph.D., Vice President, Discovery and Product, Recursion Pharmaceuticals
Dr. Alfa is Vice President, Discovery and Product at Recursion Pharmaceuticals where he manages scientific product development and external alliances across Recursion’s AI-enabled discovery platform. Dr. Alfa’s scientific contributions prior to Recursion span Neurosciences, Metabolism, and Genetics.
Presentation Title and Company Description
AI and Data Science Showcase: Massive Parallelization of Drug Discovery Using AI
Recursion combines experimental biology and bioinformatics with AI in a massively parallel system to efficiently identify treatments for diseases which can be modeled at the cellular level. The Recursion platform probes rich data from high-throughput automated screens for a number of indications, including rare disease, aging, inflammation, infectious disease, oncology, and diagnostics.